Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report

In post–liver transplant recipients, SARS-CoV-2 infection is a health threat, and novel messenger RNA vaccines such as Pfizer BioNTech BNT162b2 and Moderna mRNA-1273 are aggressively recommended. However, there are few reports on their adverse effects, some of which may be potentially fatal. We have...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Tatsuya, Okajima, Hideaki, Ogawa, Eri, Uebayashi, Elena Yukie, Yamamoto, Miki, Kadohisa, Masashi, Yamada, Yosuke, Minamiguchi, Sachiko, Haga, Hironori, Hatano, Etsurou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708617/
https://www.ncbi.nlm.nih.gov/pubmed/36572611
http://dx.doi.org/10.1016/j.transproceed.2022.11.009
_version_ 1784840975282077696
author Okamoto, Tatsuya
Okajima, Hideaki
Ogawa, Eri
Uebayashi, Elena Yukie
Yamamoto, Miki
Kadohisa, Masashi
Yamada, Yosuke
Minamiguchi, Sachiko
Haga, Hironori
Hatano, Etsurou
author_facet Okamoto, Tatsuya
Okajima, Hideaki
Ogawa, Eri
Uebayashi, Elena Yukie
Yamamoto, Miki
Kadohisa, Masashi
Yamada, Yosuke
Minamiguchi, Sachiko
Haga, Hironori
Hatano, Etsurou
author_sort Okamoto, Tatsuya
collection PubMed
description In post–liver transplant recipients, SARS-CoV-2 infection is a health threat, and novel messenger RNA vaccines such as Pfizer BioNTech BNT162b2 and Moderna mRNA-1273 are aggressively recommended. However, there are few reports on their adverse effects, some of which may be potentially fatal. We have experienced 2 post–liver transplant recipients with exacerbated chronic rejection after vaccination, one of whom had to undergo retransplant and the other who is still in the process of liver function without improvement. These alarming cases will be presented as case reports.
format Online
Article
Text
id pubmed-9708617
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97086172022-11-30 Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report Okamoto, Tatsuya Okajima, Hideaki Ogawa, Eri Uebayashi, Elena Yukie Yamamoto, Miki Kadohisa, Masashi Yamada, Yosuke Minamiguchi, Sachiko Haga, Hironori Hatano, Etsurou Transplant Proc Article In post–liver transplant recipients, SARS-CoV-2 infection is a health threat, and novel messenger RNA vaccines such as Pfizer BioNTech BNT162b2 and Moderna mRNA-1273 are aggressively recommended. However, there are few reports on their adverse effects, some of which may be potentially fatal. We have experienced 2 post–liver transplant recipients with exacerbated chronic rejection after vaccination, one of whom had to undergo retransplant and the other who is still in the process of liver function without improvement. These alarming cases will be presented as case reports. Elsevier Inc. 2023-04 2022-11-30 /pmc/articles/PMC9708617/ /pubmed/36572611 http://dx.doi.org/10.1016/j.transproceed.2022.11.009 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Okamoto, Tatsuya
Okajima, Hideaki
Ogawa, Eri
Uebayashi, Elena Yukie
Yamamoto, Miki
Kadohisa, Masashi
Yamada, Yosuke
Minamiguchi, Sachiko
Haga, Hironori
Hatano, Etsurou
Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
title Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
title_full Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
title_fullStr Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
title_full_unstemmed Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
title_short Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report
title_sort two cases of possible exacerbation of chronic rejection after anti-sars-cov-2 messenger rna vaccination: a case report
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708617/
https://www.ncbi.nlm.nih.gov/pubmed/36572611
http://dx.doi.org/10.1016/j.transproceed.2022.11.009
work_keys_str_mv AT okamototatsuya twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT okajimahideaki twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT ogawaeri twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT uebayashielenayukie twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT yamamotomiki twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT kadohisamasashi twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT yamadayosuke twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT minamiguchisachiko twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT hagahironori twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport
AT hatanoetsurou twocasesofpossibleexacerbationofchronicrejectionafterantisarscov2messengerrnavaccinationacasereport

Ejemplares similares